Send Message
View as an RSS Feed
  • The FDA approves NuPathe's (PATH) Zecuity for the acute treatment of migraine with or without aura in adults. The drug is a single-use, battery-powered patch that actively delivers sumatriptan, the most widely prescribed migraine medication, through the skin. Shares surge +18% after resuming trade following an earlier halt[View news story]
    Zecuity sounds really unique. According to http://bit.ly/YkOssW, the medicine is actually delivered by a battery powered pack. It sounds like a great help for those who suffer from migraines.
    Jan 22, 2013. 11:38 AM | Likes Like |Link to Comment
  • Amarin: 3 Things To Investigate (Further) For Vascepa  [View article]
    Vascepa, according to http://bit.ly/Wh6XJe, is especially helpful for patients who combine it with a low-fat, low-cholesterol diet. Do whatever it takes to protect your heart!
    Jan 17, 2013. 05:21 AM | Likes Like |Link to Comment
  • Buy Human Genome Sciences, The Benefit May Outweigh The Risk  [View article]
    If I'm reading this article correctly, http://bit.ly/SHO0Tw, Albiglutide works by extending the life of the stomach peptides that keep blood sugar down.  Sounds very useful!
    Jan 16, 2013. 01:34 AM | Likes Like |Link to Comment
  • Pooled analysis demonstrated reductions in systolic blood pressure with empagliflozin, an investigational SGLT-2 inhibitor, independent of changes in blood glucose and weight in adults with type 2 diabetes 
    According to http://bit.ly/VRUnPG, Empagliflozin has been shown to "reduce blood glucose by inhibiting glucose reabsorption in the kidney, resulting in significant change in HbA1c independently of beta cell function and insulin resistance." It should be helpful for many people.
    Jan 9, 2013. 01:53 AM | Likes Like
  • The FDA's approval of Alexza Pharmaceutical's (ALXA) Adasuve comes with several post-approval requirements, including a large observational clinical trial to gather patient safety data based on real-world use, as well as a clinical program addressing the safety and efficacy of the drug adolescent patients. Shares -11% AH.  [View news story]
    According to http://bit.ly/12T81qQ, it seems that Adasuve will be available in late 2013. That should help ALXA as well.
    Dec 28, 2012. 04:34 AM | Likes Like |Link to Comment
  • NPS Pharmaceuticals: Buy If There Is A Dip  [View article]
    This is great news, but keep your eyes open for serious side effects. According to http://bit.ly/12IZE1Z, these can include:
    -stomach area (abdomen) pain or swelling
    -skin reaction where the injection was given
    -cold or flu like symptoms
    If you experience any of these, let your doctor know immediately.
    Dec 27, 2012. 03:37 PM | Likes Like |Link to Comment
  • FDA Approves Aegerion Pharmaceuticals' JUXTAPID(TM) (lomitapide) Capsules for Homozygous Familial Hypercholesterolemia (HoFH) 
    Juxtapid has only been tested in those with HoFH (according to http://bit.ly/10nzrGH).

    Will further research being conducted along these lines? Surely there are others who could benefit from lowering bad cholesterol.
    Dec 27, 2012. 11:21 AM | Likes Like
  • Vertex Is Ready To Rise On Incivek Success  [View article]
    We'll see how Incivek holds up after todays news. According to this article http://bit.ly/WsVBpS, the FDA will soon require that manufacturers explain how dangerous Incivek can be.
    Dec 19, 2012. 04:36 PM | Likes Like |Link to Comment
  • Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts  [View article]
    It's official. The FDA has approved Ponatinib. You can learn more here: http://bit.ly/QYRlvp
    Dec 14, 2012. 04:13 PM | 1 Like Like |Link to Comment
  • Bristol-Myers Squibb: Buy Before Eliquis Entry In 2013  [View article]
    It sounds like you're expecting Eliquis to be a game changer. As a "blood thinner", it has a number of possible uses, such as "preventing blood clots in patients who have knee or hip replacements," and preventing strokes (http://bit.ly/SARCmq). Hopefully Wall Street won't get in the way of this making its way to patients.
    Dec 6, 2012. 01:48 PM | Likes Like |Link to Comment
  • Forxiga For Type 2 Diabetes Is A Potential Blockbuster - Buy AstraZeneca  [View article]
    According to this, Forxiga is now available in the EU (http://bit.ly/VjPIFc). How long until you think the FDA will approve it?
    Dec 4, 2012. 02:13 PM | Likes Like |Link to Comment
  • FDA Approves COMETRIQ™ (Cabozantinib) for Treatment of Progressive, Metastatic Medullary Thyroid Cancer 
    If you're looking for more information on exactly how Cometriq works, check out: http://bit.ly/UwTZZz.
    Nov 30, 2012. 03:13 PM | Likes Like
1 Like